Rang	Name	Position
1	Dr. Scott N. Braunstein M.D.	CEO, President & Chairman
2	Mr. Steven E. Pfanstiel C.M.A., M.B.A.	COO, CFO & Treasurer
3	Dr. Joseph Hulihan M.D.	Chief Medical Officer
4	Dr. Alex Aimetti Ph.D.	Chief Scientific Officer
5	Ms. Sonya Weigle	Senior VP of Investor Relations, Human Resources & Corporate Affairs
6	Ms. Martha E. Manning Esq., J. D.	Senior VP, General Counsel & Secretary
7	Molly Cameron	Director of Corporate Communications & Investor Relations
8	Dr. Kimberly A. McCormick Pharm.D.	Chief Regulatory & Quality Assurance Officer
9	Ms. Christina Shafer	Chief Commercial Officer
10	Mr. David Czekai	Chief Chemistry, Manufacturing & Controls Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Beryl Capital Management LLC	7,66%	2,33 Mio. USD
2	Morgan Stanley - Brokerage Accounts	5,97%	1,82 Mio. USD
3	ODDO BHF Asset Management SAS	4,89%	1,49 Mio. USD
4	Bain Capital Life Sciences Investors, LLC	4,88%	1,48 Mio. USD
5	Aberdeen Group PLC	4,81%	1,46 Mio. USD
6	Vanguard Group Inc	4,70%	1,43 Mio. USD
7	Woodline Partners LP	4,23%	1,29 Mio. USD
8	GSA Capital Partners LLP	3,33%	1,01 Mio. USD
9	TANG CAPITAL MANAGEMENT LLC	2,97%	0,90 Mio. USD
10	BlackRock Inc	1,60%	0,49 Mio. USD
11	Geode Capital Management, LLC	0,96%	0,29 Mio. USD
12	Citadel Advisors Llc	0,91%	0,28 Mio. USD
13	JPMorgan Chase & Co	0,88%	0,27 Mio. USD
14	Prudential Investment Management Inc	0,70%	0,21 Mio. USD
15	Schroder Investment Management Group	0,53%	0,16 Mio. USD
16	UBS Group AG	0,47%	0,14 Mio. USD
17	Royal Bank of Canada	0,45%	0,14 Mio. USD
18	Millennium Management LLC	0,43%	0,13 Mio. USD
19	State Street Corp	0,40%	0,12 Mio. USD
20	XTX Topco Ltd	0,40%	0,12 Mio. USD